Pediatrix appoints Dr. James Swift as CEO; Mark Ordan becomes Executive Chair

Pediatrix Medical Group, Inc.

James D. Swift, M.D., named CEO effective Jan 1, 2023; succeeds Mark S. Ordan.
Mark Ordan appointed Executive Chair of the Board; Guy Sansone becomes Lead Independent Director.
Swift's base salary increased to $650,000; annual bonus opportunity set at 125% of base.
Ordan to receive $60,000 monthly fee as Executive Chair through June 30, 2023.
Swift, a physician and former COO, joined Pediatrix in 2009 through an acquisition.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Mark S. Ordan

Executive Chair of the Board

MD · Pediatrix Medical Group, Inc.

Effective: 2023-01-01
Filed: December 16, 2022, 6:59 PM ET

Mr. Mark S. Ordan, who has been appointed as the Executive Chair of the Board

Appointed

James D. Swift, M.D.

Chief Executive Officer

MD · Pediatrix Medical Group, Inc.

Effective: 2023-01-01
Successor: Mark S. Ordan
Filed: December 16, 2022, 6:59 PM ET

appointed James D. Swift, M.D., as the Company’s Chief Executive Officer and principal executive officer to succeed Mr. Mark S. Ordan

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark S. Ordan was appointed as Executive Chair of the Board at Pediatrix Medical Group, Inc..

Action: appointed
Role: Executive Chair of the Board

Exact text from the filing

Mr. Mark S. Ordan, who has been appointed as the Executive Chair of the Board

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

James D. Swift, M.D. was appointed as Chief Executive Officer at Pediatrix Medical Group, Inc..

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

appointed James D. Swift, M.D., as the Company’s Chief Executive Officer and principal executive officer to succeed Mr. Mark S. Ordan

View on SEC.gov

Pediatrix Medical Group, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-22-026632

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.